Clinical Trial Update: TAVR for Aortic Regurgitation Under TTE Guidance [NA]

View source ↗

Summary

A clinical trial evaluating transcatheter aortic valve replacement for aortic regurgitation is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Regurgitation

Drugs mentioned

• Transcatheter Aortic Valve Replacement (TAVR) device (transcatheter aortic valve replacement device)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR) | NA | Status: NOT_YET_RECRUITING